TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
IBIO

iBio, Inc.

Healthcare · Biotechnology

1.20$ +0.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

iBio, Inc. (IBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow IBIO
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-4.7 -8.1 -13 -13 -14 -13 -30 -38 -30 -19 -15 -23
0.4 0.9 1.7 1.7 1.7 2.2 2.4 3.8 1.4 1.3 0.3 0.1
0.9 1.2 1.0 0.8 0.2 0.4 1.6 4.4 4.4 2.0 1.5 1.4
1.0 0.4 1.0 0.8 0.4 0.4 1.9 5.7 27 – – –
0.6 0.4 0.3 0.1 1.5 0.5 -11 3.2 5.9 -3.2 0.5 2.5
0.2 0.1 1.6 1.1 1.0 1.2 5.2 7.3 5.7 0.2 0.0 0.6
-0.2 -0.1 -1.6 -1.1 -1.0 -1.2 -26 -5.1 7.0 0.9 0.7 -32
0.0 0.0 0.0 0.0 – 22 – – 0.5 – – –
11 7.2 0.0 -0.1 -0.2 -41 – 0.0 0.0 0.0 0.0 –
-0.6 -0.6 -0.2 -0.2 -0.2 -1.5 -0.3 -5.8 -9.1 -1.1 -0.7 15
11 22 -0.2 22 3.5 65 79 -5.8 2.3 24 8.9 103
5.9 14 -15 7.8 -12 51 22 -55 -21 6.8 -5.6 48
-4.9 -8.1 -15 -15 -15 -14 -35 -45 -36 -19 -15 -24

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?